晚期口咽癌患者肌肉减少症的临床意义
本研究回顾性分析113例晚期口咽癌患者,其中32例存在肌肉减少症。肌肉减少症患者年龄更大、男性比例更低、BMI更低。结论认为肌肉减少症是影响总生存期的预后因素,且独立于HPV状态。
要点
- 肌肉减少症在生存模型中未达统计学显著,但与死亡和复发风险增加相关。
核心结论
- 肌肉减少症是影响晚期口咽癌患者总生存期的预后因素,且独立于HPV状态。
研究设计与样本
- 单中心回顾性研究,纳入113例晚期口咽癌患者,分析治疗前PET-CT图像评估肌肉减少症。
主要发现
- 多变量模型中HPV阳性与改善的无病生存期和总生存期相关;肌肉减少症在生存模型中未达统计学显著,但与死亡和复发风险增加相关。
临床怎么用
- 对晚期口咽癌患者,可考虑通过治疗前PET-CT评估肌肉减少症以辅助预后分层。
局限性
- 单中心回顾性研究,样本量有限(113例),肌肉减少症在生存模型中的独立作用未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We investigated the prevalence and impact of sarcopenia on disease-free survival (DFS) and overall survival (OS) in advanced oropharyngeal cancer. STUDY DESIGN: Retrospective study. SETTING: Single-institution tertiary cancer care center. SUBJECTS AND METHODS: We identified patients with advanced oropharyngeal cancer with pretreatment positron emission tomography-computed tomography scans for image analysis. Data were collected on the following variables: age, sex, smoking and alcohol status, stage (TNM and American Joint Committee on Cancer), human papillomavirus (HPV) status, body mass index (BMI), and treatment modality. RESULTS: Of 113 patients identified with oropharyngeal cancer, 32 had sarcopenia: these patients were older (63.5 vs 57.6 years, P = .01), were less likely to be male (53.1% vs 76.5%, P = .03), and had a lower mean BMI (24.5 vs 28.4 kg/m2, P = .009). Eighty-five subjects had HPV-positive disease, and they had a higher BMI (28.2 vs 24.2 kg/m2, P = .01) than that of patients without HPV. Twenty-one subjects who were HPV positive had less cancer recurrence (24.7% vs 48.1%, P = .04) than that of their HPV-negative counterparts. Log-rank testing showed no difference in DFS ( P = .06) associated with sarcopenia but a significant difference in OS ( P = .049). There were differences in DFS ( P = .009) and OS ( P = .023) based on HPV status. According to univariable and multivariable models, HPV positivity exhibited improved DFS and OS. Sarcopenia was not statistically significant in survival models; however, it was associated with increased mortality and recurrence. CONCLUSION: Sarcopenia is a prognostic factor affecting OS independent of HPV status in advanced oropharyngeal cancer.
引用
- Tamaki A, Manzoor NF, Babajanian E, et al. Clinical Significance of Sarcopenia among Patients with Advanced Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2018. PMID: 30105922. doi:10.1177/0194599818793857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。